Pihlajalinna Oyj provides social and healthcare services for private persons, companies, insurance companies, municipalities, and hospital districts in Finland. More Details
Solid track record with moderate growth potential.
Share Price & News
How has Pihlajalinna Oyj's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PIHLIS is less volatile than 75% of Finnish stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: PIHLIS's weekly volatility (3%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: PIHLIS underperformed the Finnish Healthcare industry which returned 13.1% over the past year.
Return vs Market: PIHLIS underperformed the Finnish Market which returned 1.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Pihlajalinna Oyj's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 years ago | Simply Wall StPihlajalinna Oyj (HEL:PIHLIS) Delivered A Weaker ROE Than Its Industry
2 years ago | Simply Wall StWhat Should Investors Know About Pihlajalinna Oyj's (HEL:PIHLIS) Return On Capital?
2 years ago | Simply Wall StPihlajalinna Oyj (HEL:PIHLIS): Did It Outperform The Industry?
Is Pihlajalinna Oyj undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PIHLIS (€11.52) is trading below our estimate of fair value (€14.96)
Significantly Below Fair Value: PIHLIS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: PIHLIS is poor value based on its PE Ratio (29.8x) compared to the XE Healthcare industry average (26.9x).
PE vs Market: PIHLIS is poor value based on its PE Ratio (29.8x) compared to the Finnish market (29x).
Price to Earnings Growth Ratio
PEG Ratio: PIHLIS is poor value based on its PEG Ratio (1.6x)
Price to Book Ratio
PB vs Industry: PIHLIS is overvalued based on its PB Ratio (2.4x) compared to the XE Healthcare industry average (2.3x).
How is Pihlajalinna Oyj forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PIHLIS's forecast earnings growth (18.4% per year) is above the savings rate (0.3%).
Earnings vs Market: PIHLIS's earnings (18.4% per year) are forecast to grow faster than the Finnish market (17.6% per year).
High Growth Earnings: PIHLIS's earnings are forecast to grow, but not significantly.
Revenue vs Market: PIHLIS's revenue (4.3% per year) is forecast to grow faster than the Finnish market (4.2% per year).
High Growth Revenue: PIHLIS's revenue (4.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PIHLIS's Return on Equity is forecast to be low in 3 years time (14.9%).
How has Pihlajalinna Oyj performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PIHLIS has high quality earnings.
Growing Profit Margin: PIHLIS's current net profit margins (1.7%) are higher than last year (0.6%).
Past Earnings Growth Analysis
Earnings Trend: PIHLIS's earnings have grown by 0.9% per year over the past 5 years.
Accelerating Growth: PIHLIS's earnings growth over the past year (159.2%) exceeds its 5-year average (0.9% per year).
Earnings vs Industry: PIHLIS earnings growth over the past year (159.2%) exceeded the Healthcare industry 17.8%.
Return on Equity
High ROE: PIHLIS's Return on Equity (7.8%) is considered low.
How is Pihlajalinna Oyj's financial position?
Financial Position Analysis
Short Term Liabilities: PIHLIS's short term assets (€94.4M) do not cover its short term liabilities (€132.1M).
Long Term Liabilities: PIHLIS's short term assets (€94.4M) do not cover its long term liabilities (€195.0M).
Debt to Equity History and Analysis
Debt Level: PIHLIS's debt to equity ratio (81.7%) is considered high.
Reducing Debt: PIHLIS's debt to equity ratio has increased from 14.9% to 81.7% over the past 5 years.
Debt Coverage: PIHLIS's debt is well covered by operating cash flow (50.2%).
Interest Coverage: PIHLIS's interest payments on its debt are well covered by EBIT (4.7x coverage).
What is Pihlajalinna Oyj current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: PIHLIS's dividend (1.74%) is higher than the bottom 25% of dividend payers in the Finnish market (1.73%).
High Dividend: PIHLIS's dividend (1.74%) is low compared to the top 25% of dividend payers in the Finnish market (3.65%).
Stability and Growth of Payments
Stable Dividend: PIHLIS has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: PIHLIS's dividend payments have increased, but the company has only paid a dividend for 4 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (51.8%), PIHLIS's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: PIHLIS's dividends in 3 years are forecast to be well covered by earnings (35.9% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Joni Raimo Aaltonen (50 yo)
Mr. Joni Raimo Mikael Aaltonen has been Chief Executive Officer of Pihlajalinna Oyj since December 11, 2017 and has been its Chairman of the Management Team since August 15, 2019. He was Director of VMP Oy...
CEO Compensation Analysis
Compensation vs Market: Joni Raimo's total compensation ($USD518.69K) is about average for companies of similar size in the Finnish market ($USD640.59K).
Compensation vs Earnings: Joni Raimo's compensation has increased by more than 20% in the past year.
Experienced Management: PIHLIS's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Experienced Board: PIHLIS's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Pihlajalinna Oyj's company bio, employee growth, exchange listings and data sources
- Name: Pihlajalinna Oyj
- Ticker: PIHLIS
- Exchange: HLSE
- Founded: 2001
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: €259.720m
- Shares outstanding: 22.58m
- Website: https://www.pihlajalinna.fi
Number of Employees
- Pihlajalinna Oyj
- Kehräsaari B
Pihlajalinna Oyj provides social and healthcare services for private persons, companies, insurance companies, municipalities, and hospital districts in Finland. It offers general practitioner and medical s...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/19 17:38|
|End of Day Share Price||2021/04/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.